
Cordex Expands Zemcelpro Access to Argentina, Hong Kong and Singapore
Cordex has tapped FarmaMondo to distribute Zemcelpro, a specialized cell therapy for blood cancers, across Argentina, Hong Kong and Singapore. This agreement aims to navigate complex regulatory landscapes and provide early patient access to the personalized stem cell product, which recently secured conditional approval in the European Union.



























